Skip to main content

Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular’s International Product Information. This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professionaloperators.

xTAG® Nucleic Acid Assay Technology

A flexible solution for performing multiplexed nucleic acid assays

xTAG® Technology uses a proprietary universal tag system that allows easy development and optimization of nucleic acid assays. xTAG® Technology combined with Luminex instruments is a complete solution for mid-density arrays evaluating gene expression, genotypes, or miRNA. Several nucleic acid tests from Luminex are based on xTAG® Technology.

xTAG® Nucleic Acid Assay Technology - Diasorin

How does xTAG® Technology work?

The TAG portion of the name represents TAG technology. TAG technology constitutes the proprietary sequences designed by Luminex for nucleic acid applications.

xTAG® Technology

Optimized sequences

Sequences have been optimized to minimize cross-hybridization, thus preventing cross-talk in multiplexed nucleic acid assays.

Only 3 TAG

Only three bases are used (TAG), preventing hybridization with native sequences.

Reduced operational time

Isothermal hybridization prevents long experimental design and testing times.


Diasorin document repository


Luminex document repository

Discover more

Research publications

Discover more